Organization and Description of Business and Recent Developments (Details)	12 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
Description of biotechnology research development	Preclinical studies have also indicated that DHA-dFdC inhibits pancreatic cancer cell growth (up to 100,000-fold more potent that gemcitabine, a current standard therapy), targets pancreatic tumors and has demonstrated activities against other cancers, including leukemia, lung and melanoma.